These results support the idea that EpICD-induced upregulation of Wnt receptor transcription and consequent activation of Wnt signaling promotes CRC progression, which however the mechanisms can be neutralized by hEpAb2-6 treatment in order to provide therapeutic benefit (Fig. 6j). This evidence concerns the gene FZD1 and colorectal carcinoma.